文献速递心脑血管急症重症综合管理与镇静镇痛

渥太华心力衰竭风险量表的前瞻性明确临床验证:联合与不联合定量NT-proBNP

Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT-proBNP.
PubMed 文献 · Acad Emerg Med · 2017-01-01
一句话结论前瞻性验证显示,渥太华心力衰竭风险量表(OHFRS)评分>1分对急性心衰30天严重不良事件高度敏感,但会提高住院率;有NT-proBNP时敏感性进一步提高。

本研究为六家三级医院急诊科的前瞻性观察性队列研究,纳入1100例急性心衰患者,由急诊医师评估10项OHFRS标准并随访30天,在可行时检测定量NT-proBNP。严重不良事件(SAE)定义为30天内死亡、入住监护病房、插管、无创通气、心肌梗死或14天内复发再住院,共170例(15.5%)发生SAE(住院者19.4%,离院者10.2%)。与实际实践相比,采用OHFRS评分>1分作为住院阈值可提高敏感性(71.8% vs 91.8%),但增加住院率(57.2% vs 77.6%);在684例有NT-proBNP值的患者中,评分>1分同样显著提高敏感性(69.8% vs 95.8%),住院率亦增加(60.8% vs 88.0%);仅11.9%的病例医师表示对使用OHFRS感到不适。作者认为,经过充分医师培训,OHFRS应有助于改善和标准化住院决策,减少低危患者的不必要住院和高危患者的不安全离院。

要点

  • 在1100例急诊急性心衰患者中,30天SAE发生率为15.5%(住院者19.4%,离院者10.2%)。
  • 采用OHFRS评分>1分作为住院阈值,与实际实践相比敏感性由71.8%升至91.8%,住院率由57.2%升至77.6%。
  • 在684例有NT-proBNP值的患者中,评分>1分使敏感性由69.8%升至95.8%,住院率由60.8%升至88.0%。
  • 仅11.9%的病例医师表示对使用OHFRS感到不适。
  • 作者认为,经过充分医师培训,OHFRS应有助于改善和标准化住院决策,减少低危患者的不必要住院和高危患者的不安全离院。

适用人群与场景

  • 六家三级医院急诊科就诊的急性心力衰竭患者,由急诊医师进行评估并随访30天。
  • 在可行时检测定量NT-proBNP;684例患者有NT-proBNP值。

诊断标准与关键阈值

  • OHFRS包含10项标准,由急诊医师评估。
  • 住院阈值为OHFRS评分>1分。
  • SAE定义为30天内死亡、入住监护病房、插管、无创通气、心肌梗死或14天内复发导致再住院。

研究设计与关键结果

  • 前瞻性观察性队列研究,纳入1100例急性心衰患者,平均年龄77.7(±10.7)岁。
  • 170例(15.5%)发生SAE:住院者19.4%,离院者10.2%。
  • 与实际实践相比,采用OHFRS评分>1分住院阈值使敏感性从71.8%升至91.8%,住院率从57.2%升至77.6%。
  • 在684例有NT-proBNP值的患者中,评分>1分使敏感性从69.8%升至95.8%,住院率从60.8%升至88.0%。
  • 仅11.9%的病例医师表示对使用OHFRS感到不适。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究,在六家三级医院急诊科开展。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,经过充分医师培训,OHFRS应有助于改善和标准化住院决策,减少低危患者的不必要住院和高危患者的不安全离院。
  • 使用OHFRS评分>1分作为住院阈值可提高对SAE的敏感性,但会相应增加住院率;有NT-proBNP时敏感性进一步提高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: We previously developed the Ottawa Heart Failure Risk Scale (OHFRS) to assist with disposition decisions for acute heart failure patients in the emergency department (ED). We sought to prospectively evaluate the accuracy, acceptability, and potential impact of OHFRS.

METHODS: This prospective observational cohort study was conducted at six tertiary hospital EDs. Patients with acute heart failure were evaluated by ED physicians for the 10 OHFRS criteria and then followed for 30 days. Quantitative NT-proBNP was measured where feasible. Serious adverse event (SAE) was defined as death within 30 days, admission to monitored unit, intubation, noninvasive ventilation, myocardial infarction, or relapse resulting in hospital admission within 14 days.

RESULTS: We enrolled 1,100 patients with mean (±SD) age 77.7 (±10.7) years. SAEs occurred in 170 (15.5%) cases (19.4% if admitted and 10.2% if discharged). Compared to actual practice, using an admission threshold of OHFRS score > 1 would have increased sensitivity (71.8% vs. 91.8%) but increased admissions (57.2% vs. 77.6%). For 684 cases with NT-proBNP values, using a threshold score > 1 would have significantly increased sensitivity (69.8% vs. 95.8%) while increasing admissions (60.8% vs. 88.0%). In only 11.9% of cases did physicians indicate discomfort with use of OHFRS.

CONCLUSION: Prospective clinical validation found the OHFRS tool to be highly sensitive for SAEs in acute heart failure patients, albeit with an increase in admission rates. When available, NT-proBNP values further improve sensitivity. With adequate physician training, OHFRS should help improve and standardize admission practices, diminishing both unnecessary admissions for low-risk patients and unsafe discharge decisions for high-risk patients.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Stiell IG, Perry JJ, Clement CM, et al. Prospective and Explicit Clinical Validation of the Ottawa Heart Failure Risk Scale, With and Without Use of Quantitative NT-proBNP. Acad Emerg Med. 2017. PMID: 27976497. doi:10.1111/acem.13141

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。